Drug Profile
Research programme: monoclonal antibody therapeutics - Theraclone
Latest Information Update: 23 Mar 2010
Price :
$50
*
At a glance
- Originator Theraclone Sciences
- Class Monoclonal antibodies
- Mechanism of Action Granulocyte macrophage colony stimulating factor antagonists; Interferon alpha inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Autoimmune disorders; Inflammation
Most Recent Events
- 23 Mar 2010 Preclinical trials in Autoimmune disorders in USA (Parenteral)
- 23 Mar 2010 Preclinical trials in Inflammation in USA (Parenteral)